← FDA Drug Approvals (Drugs@FDA)

SDAMLO

NDA · New Drug Application · Sponsor: BRILLIAN PHARMA · Approved 2025-07-24

Drug application

FDA Application #

NDA219531

Application type

New Drug Application

Brand name

SDAMLO

Generic name

AMLODIPINE

Active ingredients

AMLODIPINE BESYLATE

Dosage form

FOR SOLUTION

Route

ORAL

Marketing status

Prescription

Sponsor

BRILLIAN PHARMA

Manufacturer

Pangea Pharmaceuticals, LLC

First approval

2025-07-24

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown